Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed ...
Chirality, a property where structures have a distinct left- or right-handedness, allows natural semiconductors to move ...
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads ...
The Center for Convergent Bioscience and Medicine (CCBM), The University of Alabama, Tuscaloosa, Alabama 35487, United States Bioscience and Medicine Initiative, College of Community Health Sciences, ...
AimedBio sells ADC drug technology to Boehringer Ingelheim for up to 1.4 trillion won AimedBio licenses next‑gen ADC to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results